Mar
02
The Lone Analyst Who Said Sell Valeant When Hedge Funds Piled In
By-
Khmelnitsky watched shares double in a year, before crashing
-
`I stayed with the call,’ Veritas analyst says in interview
In July 2014, Dimitry Khmelnitsky advised investors to sell Valeant Pharmaceuticals International Inc. and then watched the stock double in a year.
“It was very painful,” Khmelnitsky, an analyst at Veritas Investment Research Corp., said in an telephone interview from his office in Toronto. “What I felt was pain.”…
The Lone Analyst Who Said Sell Valeant When Hedge Funds Piled In
